Tribenzor (Daiichi Sankyo, Inc.)


Welcome to the PulseAid listing for the Tribenzor drug offered from Daiichi Sankyo, Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Daiichi Sankyo, Inc.
NON-PROPRIETARY NAME: olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
SUBSTANCE NAME: OLMESARTAN MEDOXOMIL; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-07-31
END MARKETING DATE: 0000-00-00


Tribenzor HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTribenzor from Daiichi Sankyo, Inc.
LABELER NAME: Daiichi Sankyo, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20; 5; 12.5(mg/1; mg/1; mg/1)
START MARKETING DATE: 2010-07-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65597-114_ef0729da-0645-42fd-9c27-ad722fe88ef1
PRODUCT NDC: 65597-114
APPLICATION NUMBER: NDA200175

Other OLMESARTAN MEDOXOMIL; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Daiichi Sankyo, Inc.Tribenzor
Par Pharmaceutical, Inc.olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Sun Pharmaceutical Industries, Inc.Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide
Teva Pharmaceuticals USA, Inc.Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide